摘要 |
<p>The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as modulator of retinoid-related orphan receptor gamma t (RORγt). These compounds prevent, inhibit, or suppress the action of RORγt and are therefore useful in the treatment of RORγt mediated disease, disorder, syndrome or condition such as pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, neurodegenerative diseases or cancer.</p> |
申请人 |
GLENMARK PHARMACEUTICALS S.A. |
发明人 |
CHAUDHARI, SACHIN SUNDARLAL;THOMAS, ABRAHAM;DHONE, SACHIN VASANTRAO;KHAIRATKAR-JOSHI, NEELIMA;BAJPAI, MALINI |